Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Jefferam1


ATBPF

RE:RE:RE:Antibe Therapeutics grants options to purchase common shares

I was under the same impression, infact, their corporte presentation: http...

April 3, 2017

ATBPF

Antibe Therapeutics grants options to purchase common shares

Antibe Therapeutics Inc. ("Antibe" or the "Company"...

April 3, 2017

ATBPF

RE:My daughter the nerd asks real questions

Correct me if I'm wrong but much of the past test done with NicOx was...

March 29, 2017

ATBPF

RE:Previous post

This is very interesting. I'm not aware of Wallace previous work. This...

March 26, 2017

ATBPF

RE:RE:Zacks

1 - I try to post the honest truth (and sometime opinions). ...

March 25, 2017

ATBPF

Zacks

http://scr.zacks.com/Coverage/Biotech-David-Bautz-PhD/default.aspx I was...

March 23, 2017

ATBPF

0.19 - Possible reason

On March 10th, Antibe filed to be qualified for a short form prospectus...

March 23, 2017

ATBPF

RE:RE:Definitely worth read - initiation of coverage (C$1.25 targ)

we estimate the net present value of ATB-346 to be $171 million

March 22, 2017

ATBPF

RE:Definitely worth read - initiation of coverage (C$1.25 targ)

WOW That is encouraging. "With a conservatively estimated 6% of the...

March 22, 2017

ATBPF

RE:New article on CEO Dan Legault and Antibe

I just read the CEO article and sounds very promissing. Nothing really new...

March 15, 2017

ATBPF

New article on CEO Dan Legault and Antibe

https://www.twst.com/interview/Interview-with-the-CEO-and-Director-Antibe...

March 10, 2017

ATBPF

RE:ATE Trading

Ok I spoke too soon, 3K traded. On another topic, here is an example of how...

March 2, 2017

ATBPF

ATE Trading

So let me get this straight. Financials have been released last night. The...

March 2, 2017

ATBPF

RE:RE:Antibe Therapeutics Reports Q3 2017 Interim Financial and Op

If the development of ATB-346 proceeds as planned, and the scientific results...

March 2, 2017

ATBPF

RE:RE:RE:RE:RE:RE:NR says 1% of Market which means

It's 5% royality. I think that sounds about on par with what a lot of...

February 24, 2017

ATBPF

RE:RE:RE:RE:RE:RE:NR says 1% of Market which means

To give you an approximate amount, I have less then 10x your holdings...

February 24, 2017

ATBPF

RE:RE:RE:RE:NR says 1% of Market which means

Maybe you bought some of mine. I sold about 20 000 share although i think it...

February 24, 2017

ATBPF

RE:RE:nice !

TSX-Venture Symbol: ATE Resumption (ET): 11:30 AM Let's see if...

February 24, 2017

ATBPF

RE:RE:RE:RE:RE:Assumption?

Scrap that July 1st date. All previous investor presentations said PHase 2...

February 20, 2017

ATBPF

RE:RE:RE:Assumption?

July 1st can't come soon enough for shareholders of ATE. Looking forward...

February 17, 2017